EA201991877A3 - 7-бензил-4-(2-метилбензил)-2,4,6,7,8,9-гексагидроимидазо[1,2- a]пиридо[3,4-e]пиримидин-5(1h)-он, его соли и способы применения - Google Patents
7-бензил-4-(2-метилбензил)-2,4,6,7,8,9-гексагидроимидазо[1,2- a]пиридо[3,4-e]пиримидин-5(1h)-он, его соли и способы примененияInfo
- Publication number
- EA201991877A3 EA201991877A3 EA201991877A EA201991877A EA201991877A3 EA 201991877 A3 EA201991877 A3 EA 201991877A3 EA 201991877 A EA201991877 A EA 201991877A EA 201991877 A EA201991877 A EA 201991877A EA 201991877 A3 EA201991877 A3 EA 201991877A3
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- hexahydroimidazo
- pyrido
- methylbenzyl
- pyrimidine
- benzyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Настоящее изобретение относится, по меньшей мере частично, к способу лечения. В одном варианте реализации способ лечения включает введение субъекту, нуждающемуся в таком лечении, первого терапевтического агента, включающего соединение (1)или его фармацевтически приемлемую соль, в комбинации со вторым терапевтическим агентом, при этом указанные первый терапевтический агент и второй терапевтический агент вводят одновременно или последовательно.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361904718P | 2013-11-15 | 2013-11-15 | |
PCT/US2014/048241 WO2015073072A1 (en) | 2013-11-15 | 2014-07-25 | 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1h)-one |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201991877A2 EA201991877A2 (ru) | 2020-01-31 |
EA201991877A3 true EA201991877A3 (ru) | 2020-05-31 |
Family
ID=53057834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201991877A EA201991877A3 (ru) | 2013-11-15 | 2014-09-12 | 7-бензил-4-(2-метилбензил)-2,4,6,7,8,9-гексагидроимидазо[1,2- a]пиридо[3,4-e]пиримидин-5(1h)-он, его соли и способы применения |
Country Status (2)
Country | Link |
---|---|
EA (1) | EA201991877A3 (ru) |
WO (1) | WO2015073072A1 (ru) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE049013T2 (hu) | 2014-03-31 | 2020-08-28 | Scripps Research Inst | Farmakofór trail indukcióra |
WO2016079527A1 (en) | 2014-11-19 | 2016-05-26 | Tetralogic Birinapant Uk Ltd | Combination therapy |
WO2016097773A1 (en) | 2014-12-19 | 2016-06-23 | Children's Cancer Institute | Therapeutic iap antagonists for treating proliferative disorders |
HUE052821T2 (hu) | 2015-01-30 | 2021-05-28 | Oncoceutics Inc | 7-benzil-4-(4-trifluormetil)benzil-1,2,6,7,8,9-hexahidroimidazo[1,2-a]pirido[3,4-e]pirimidin-5(4H)-on és sói és azok terápiában történõ alkalmazása |
MX2018009227A (es) | 2016-01-29 | 2018-11-09 | Oncoceutics Inc | Modulacion del receptor acoplado a proteina g (gpcr) por imipridones. |
AU2017225982B2 (en) | 2016-03-02 | 2023-10-05 | Eisai R&D Management Co., Ltd. | Eribulin-based antibody-drug conjugates and methods of use |
JP7300394B2 (ja) | 2017-01-17 | 2023-06-29 | ヘパリジェニックス ゲーエムベーハー | 肝再生の促進又は肝細胞死の低減もしくは予防のためのプロテインキナーゼ阻害 |
US10172862B2 (en) | 2017-01-30 | 2019-01-08 | Oncoceutics, Inc. | Imipridones for gliomas |
CN111153891B (zh) * | 2020-01-10 | 2023-03-31 | 贵州医科大学 | 一种取代苯并咪唑类PI3Kα/mTOR双靶点抑制剂及其药物组合物和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4642345A (en) * | 1980-08-14 | 1987-02-10 | Mead Johnson & Company | 6,7-dihydro-3H-imidazo[1,2-a]-purine-9(4H)-ones |
SI2701708T1 (sl) * | 2011-04-29 | 2020-07-31 | The Penn State Research Foundation | Induciranje malomolekulskega gena TRAIL z normalnimi in tumorskimi celicami kot terapija proti raku |
-
2014
- 2014-07-25 WO PCT/US2014/048241 patent/WO2015073072A1/en active Application Filing
- 2014-09-12 EA EA201991877A patent/EA201991877A3/ru unknown
Also Published As
Publication number | Publication date |
---|---|
EA201991877A2 (ru) | 2020-01-31 |
WO2015073072A1 (en) | 2015-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201808496VA (en) | 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pytido[3.4-e]pyrimidin-5(1h)-one, salts thereof and methods of using the same in combination therapy | |
EA201991877A3 (ru) | 7-бензил-4-(2-метилбензил)-2,4,6,7,8,9-гексагидроимидазо[1,2- a]пиридо[3,4-e]пиримидин-5(1h)-он, его соли и способы применения | |
EA201691008A1 (ru) | 7-бензил-4-(2-метилбензил)-2,4,6,7,8,9-гексагидроимидазо[1,2-a]пиридо[3,4-e]пиримидин-5(1h)-он, его соли и способы применения | |
MX2023000782A (es) | 7-bencil-4-(2-metilbencilo)-2,4,6,7,8,9-hexahidroimidazo [1,2-a]pirido[3,4-e]pirimidin-5(1h)-ona, analogos y sales del mismo y su uso en terapia. | |
EA201590870A1 (ru) | АМИНОЗАМЕЩЕННЫЕ ИМИДАЗО[1,2-a]ПИРИДИНКАРБОКСАМИДЫ И ИХ ПРИМЕНЕНИЕ | |
SV2015005115A (es) | Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades | |
EA201591702A1 (ru) | Комбинация двух противовирусных препаратов для лечения гепатита c | |
EA201490254A1 (ru) | Комбинированное лечение гепатита с | |
EA201690093A1 (ru) | Производные пирроло[3,2-d]пиримидина для лечения вирусных инфекций и других заболеваний | |
EA201691385A1 (ru) | Комбинированная терапия рака | |
ZA202200511B (en) | Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of tuberculosis | |
EA201690974A1 (ru) | Гидроморфон и налоксон для лечения боли и индуцированного опиоидами синдрома дисфункции кишечника | |
MX2015013155A (es) | Formulaciones farmaceuticas de la familia de la tetrandrina y metodo. | |
EA201592242A1 (ru) | Производные пиридона для лечения вирусных инфекций и других заболеваний | |
WO2014186388A3 (en) | Administration of nedd8-activating enzyme inhibitor and chemotherapeutic agents | |
CL2014002434A1 (es) | Combinacion que comprende el compuesto n-[2-(2,1,3-benzotiadiazol-5-ilamino)-6-(2,6-diclorofenil)pirido[2,3-d]pirimidin-7-il]-n'-(1,1-dimetiletil)-urea (a) con citarabina (b); kit farmaceutico; uso en el tratamiento de leucemia mieloide aguda y leucemia mieloide crónica. | |
EA202190165A1 (ru) | 7-БЕНЗИЛ-4-(2-МЕТИЛБЕНЗИЛ)-2,4,6,7,8,9-ГЕКСАГИДРОИМИДАЗО[1,2-a]ПИРИДО[3,4-e]ПИРИМИДИН-5(1Н)-ОН, ЕГО АНАЛОГИ И СОЛИ И СПОСОБЫ ИХ ПРИМЕНЕНИЯ В ТЕРАПИИ | |
MX2015014907A (es) | Compuestos de pirazino - [1,2-a] indol, su preparacion y su uso en medicamentos. | |
TH1701000434A (th) | [1,2,4]ไตรเอโซโล[4,3-b]ไพริดาซีนสำหรับใช้ในการบำบัดโรคทางการเพิ่มจำนวน | |
TH156795A (th) | อิมิดาโซไพริดาซีนที่ถูกแทนที่ด้วยอะมิโน (amino-substituted imidazopyidazine) |